SEE BETTER. TREAT BETTER.
We are Provepharm, a pharmaceutical company focused on developing high-quality, effective, ready-to-use medical dyes designed to optimise visualisation and detection in clinical practice.
Welcome to Provepharm United Kingdom
Zyogreen® 2.5 mg/mL - Solution for injection - Indocyanine Green
Provepharm UK Ltd is launching the first ready-to-use indocyanine green. Marketing authorisation for Zyogreen® was granted by the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom in April 2026.
Discover Zyogreen® 2.5 mg/mL - For Healthcare Professionals only
Discover moreDiscover Zyogreen® 2.5 mg/mL - For General Public
Discover moreBuilding on more than 25 years of expertise, our innovation is grounded in organic chemistry and advanced formulation technologies, ensuring the quality, performance, and ease of use of our dyes in hospital settings.
Targeted Research & Development
dedicated to enhanced surgical visualisation and detection
Discover more
Regulatory expertise and secured supply chain
ensuring market access and reliable product availability
Discover more
Supporting healthcare professionals
to address their needs and support the evolution of clinical practices
Discover more
Discover how Provepharm is helping to shape the future of precision surgery.
For nearly 30 years, Provepharm’s R&D expertise has supported healthcare professionals with visualisation solutions designed to enhance the precision of medical procedures.
Media center
Press releases
Provepharm launches Zyogreen® in the UK, first ready-to-use indocyanine green
Press releases
Provepharm expands presence in medical dyes and enters fluorescence era
Press releases
Provepharm launches Blumyne™ surgical dye in UK
Press releases
Provepharm launches UK subsidiary
Provepharm is shaping the future of operating room visualisation by contributing to ever-greater precision in critical procedures and diagnosis.
At the intersection of science and care, our teams combine rigor and close collaboration to help optimise surgical procedures where precision and reliability are essential.
Provepharm’s Global Key figures
1.3 million
units sold worlwide
40
marketing authorisation & 3 CE marks
+20%
of revenues invested in R&D
15
patents families (223 patents)
Our Carbon Reduction Plan
Provepharm UK Ltd is committed to achieving a Net Zero emissions by 2050.
Join the adventure
Join the adventure
Joining Provepharm means participating in an adventure where innovation & commitment come together.
About us
About us
A pharmaceutical laboratory specialized in medical dyes designed to optimise visualisation and detection in clinical practice.